NOVARTIS’ ESSENTIAL DIVERSITY (ADD, 19% UPSIDE)
11/11/19 -"Since we last pushed Novartis’ (ADD, Switzerland) investment story – “Novartis’ rejuvenation lacks speed” – in January 2018, the stock did well, before the negative newsflow crippled sentiment from ..."
Pages
71
Language
English
Published on
11/11/19
You may also be interested by these reports :
23/04/24
The Q1 results came in ahead of the consensus as growth was supported by healthy performances across all the focus areas. Consequently, the ...
17/04/24
Q1 sales exceeded expectations, driven by a strong performance from the Companion Animal segment. The Farm Animal segment was however held back by a ...
16/04/24
Preview: Positive 1Q24 driven by clinical developments of portfolio companies
15/04/24
Investor appetite for Merck KGaA (Add, Germany) shares has been somewhat subdued since we last teased the name (15/03/2021). At that time, the ...